187 related articles for article (PubMed ID: 6085683)
1. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Chen YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
[No Abstract] [Full Text] [Related]
2. [The probenecid test and its application to research in schizophrenia].
Chen YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
[No Abstract] [Full Text] [Related]
3. Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
Bartfai A; Levander SE; Sedvall G
Biol Psychiatry; 1983 Sep; 18(9):971-87. PubMed ID: 6196060
[TBL] [Abstract][Full Text] [Related]
4. Biogenic amine metabolism in Tourette syndrome.
Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
[TBL] [Abstract][Full Text] [Related]
5. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
[No Abstract] [Full Text] [Related]
6. CSF monoamine metabolites in depression and schizophrenia.
Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
Sedvall G
Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
[TBL] [Abstract][Full Text] [Related]
8. Genetic studies of CSF monoamine metabolites.
Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
[No Abstract] [Full Text] [Related]
9. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
Bowers MB; Heninger GR
Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
[No Abstract] [Full Text] [Related]
10. CSF monoamine metabolites, depression, and suicide.
Asberg M; Bertilsson L; Mårtensson B
Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
[No Abstract] [Full Text] [Related]
11. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
van Kammen DP; Peters J; van Kammen WB
Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
[TBL] [Abstract][Full Text] [Related]
13. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
Bowers MB; Study RE
Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid amine metabolites in acute schizophrenia.
Post RM; Fink E; Carpenter WT; Goodwin FK
Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space.
Van der Poel FW; Van Praag HM; Korf J
Psychopharmacology (Berl); 1977 Mar; 52(1):35-40. PubMed ID: 403555
[TBL] [Abstract][Full Text] [Related]
18. [Monoamine metabolite levels in cerebrospinal fluid of schizophrenic patients].
Imazu Y; Kobayashi K; Kawabata M; Shohmori T
Seishin Shinkeigaku Zasshi; 1985; 87(9):634-42. PubMed ID: 2419935
[No Abstract] [Full Text] [Related]
19. Developmental variations in CSF monoamine metabolites during childhood.
Hedner J; Lundell KH; Breese GR; Mueller RA; Hedner T
Biol Neonate; 1986; 49(4):190-7. PubMed ID: 2423144
[TBL] [Abstract][Full Text] [Related]
20. The effects of psychopharmacological agents on central nervous system amine metabolism in man.
Maas JW
Annu Rev Pharmacol Toxicol; 1977; 17():411-24. PubMed ID: 17358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
